Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation-Reference-Cited by-同舟云学术

Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation

Published:2017-12 Issue:6 Volume:67 Page:1168-1176
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Pascasio Juan Manuel,Vinaixa Carmen,Ferrer María Teresa,Colmenero Jordi,Rubin Angel,Castells Lluis,Manzano María Luisa,Lorente Sara,Testillano Milagros,Xiol Xavier,Molina Esther,González-Diéguez Luisa,Otón Elena,Pascual Sonia,Santos Begoña,Herrero José Ignacio,Salcedo Magdalena,Montero José Luis,Sánchez-Antolín Gloria,Narváez Isidoro,Nogueras Flor,Giráldez Álvaro,Prieto Martín,Forns Xavier,Londoño María-Carlota

Publisher

Elsevier BV

Subject

Hepatology

Reference28 articles.

1. Viral hepatitis in liver transplantation;Crespo;Gastroenterology,2012

2. Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective study;Carrion;J Hepatol,2009

3. A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis c after liver transplantation;Everson;Hepatology,2013

4. Antiviral therapy in compensated and decompensated cirrhotic patients with chronic HCV infection;Iacobellis;Expert Opin Pharmacother,2009

5. Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study;Curry;Gastroenterology,2015

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EASL position paper on clinical follow-up after HCV cure;Journal of Hepatology;2024-08

2. Achieving SVR in patients with hepatitis C-related HCC is associated with an improvement in overall survival: real word data;Hepatoma Research;2024-07-11

3. Financial incentives to motivate treatment for hepatitis C with direct acting antivirals among Australian adults (The Methodical evaluation and Optimisation of Targeted IncentiVes for Accessing Treatment of Early-stage hepatitis C: MOTIVATE-C): protocol for a dose-response randomised controlled study;Trials;2024-06-17

4. Navigating the landscape of liver cancer management: Study designs in clinical trials and clinical practice;Journal of Hepatology;2024-06

5. Novel approaches in the medical management of compensated cirrhosis;Expert Review of Gastroenterology & Hepatology;2024-05-28